← All sarcoma trials
Recruiting now—All ages

Diagnostic and Therapeutic Targets in Cartilaginous Tumours

Sponsor: St. Anne's University Hospital Brno, Czech Republic · NCT07315542 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

ChondrosarcomasCartilage Tumours

What it tests

  • Tumour tissue analysisdiagnostic_test
  • Molecular validationdiagnostic_test
  • Liquid biopsy analysisdiagnostic_test

Where it's running1 site

1 international site

  • First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia

    Brno, South Moravian, Czechia 60200

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria

* Histologically confirmed cartilaginous (chondroid) tumour
* Diagnosis includes one of the following entities (as available and eligible):
* Enchondroma
* Atypical cartilaginous tumour / Grade 1 chondrosarcoma (ACT/G1)
* Conventional chondrosarcoma (Grade 2-3)
* Dedifferentiated chondrosarcoma
* Other rare chondrosarcoma variants (e.g., mesenchymal, clear-cell), if present in the cohort
* Patients treated and/or followed at the First Department of Orthopaedic Surgery, St. Anne's University Hospital Brno

Exclusion Criteria

* Insufficient, degraded, or otherwise unusable tissue samples

Updated 2026-01-05 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.